基础医学与临床 ›› 2025, Vol. 45 ›› Issue (11): 1444-1450.doi: 10.16352/j.issn.1001-6325.2025.11.1444

• 研究论文 • 上一篇    下一篇

IL-37抑制巨噬细胞介导的浆细胞性乳腺炎

邓友缘, 赵红军, 叶丽芬, 李靖勇, 张怀孝, 张超, 王建国*   

  1. 湘潭市中心医院 普外二科,湖南 湘潭 411199
  • 收稿日期:2025-02-27 修回日期:2025-06-23 出版日期:2025-11-05 发布日期:2025-10-24
  • 通讯作者: *wangjianguoxtszxyy@163.com
  • 基金资助:
    湖南省卫生健康委科研计划(D202304018543)

IL-37 inhibits macrophage-mediated plasma cell mastitis

DENG Youyuan, ZHAO Hongjun, YE Lifen, LI Jingyong, ZHANG Huaixiao, ZHANG Chao, WANG Jianguo*   

  1. Department of General Surgery 2, Xiangtan Central Hospital, Xiangtan 411199,China
  • Received:2025-02-27 Revised:2025-06-23 Online:2025-11-05 Published:2025-10-24
  • Contact: *wangjianguoxtszxyy@163.com

摘要: 目的 探究在浆细胞性乳腺炎中白介素-37(IL-37)是否通过核苷酸寡聚化结构域受体蛋白1(NOD1)/核因子B (NF-κB)影响巨噬细胞M1极化。方法 收集15例浆细胞性乳腺炎患者的炎性乳腺组织标本(n=15)及距离炎性乳腺组织边缘≥3 cm且镜检结果显示与正常相似的乳腺组织(n=15),RT-qPCR检测NOD1及IL-37表达。采用佛波酯(PE)诱导THP-1细胞分化为静息巨噬细胞(M0),用脂多糖(LPS)联合γ-干扰素(IFN-γ)诱导M0巨噬细胞向M1表型极化。构建NOD1慢病毒RNA干扰或过表达载体以调控NOD1在M1巨噬细胞中的表达,用IL-37重组蛋白对M0巨噬细胞进行预处理,后给予LPS及IFN-γ诱导。用RT-qPCR检测各组细胞NOD1、IL-37、M1标志物(IL-6、iNOS)、M2标志物(IL-10、Arg-1);Western blot检测NOD1、p65、p- p65蛋白水平;免疫共沉淀检测IL-37与NOD1的相互作用。结果 与正常乳腺组织相比,炎性乳腺组织表现为NOD1上调而IL-37下调(P<0.05)。相较于M0细胞,M1细胞的NOD1及M1标志物上调而IL-37下调, p65蛋白磷酸化水平升高(P<0.05)。在M1巨噬细胞中,NF-κB抑制剂及NOD1敲低均导致NOD1及M1标志物下调,并引起p65亚基磷酸化水平降低(P<0.05)。IL-37重组蛋白导致M1巨噬细胞中NOD1、M1标志物、p65亚基磷酸化水平显著降低,过表达NOD1可逆转IL-37的影响(P<0.05)。IL-37可与NOD1发生蛋白相互作用。结论 IL-37可能通过下调NOD1/NF-κB 通路活性抑制巨噬细胞的M1极化,从而阻止浆细胞性乳腺炎进展。

关键词: 浆细胞性乳腺炎, 巨噬细胞, M1极化, 白介素-37, 核苷酸寡聚化结构域受体蛋白1

Abstract: Objective To investigate whether interleukin-37 (IL-37) affects macrophage M1 polarization via nucleotide oligomerization of structural domain receptor protein 1 (NOD1)/nuclear factor κB (NF-κB) in plasma cell mastitis. Methods A total of 15 patients with plasma cell mastitis were recruited according to the collection standard as inflammatory breast tissue and normal breast tissue with a distance of ≥3 cm from the edge of the inflammatory breast tissue. QPCR was performed to detect NOD1 and IL-3. Phorbol ester(PE) was used to induce THP-1 cells to differentiate into resting macrophages (M0). Lipopolysaccharide (LPS) combined with interferon(IFN-γ) was used to induce the polarization of M0 macrophages towards the M1 phenotype. NOD1 lentiviral RNA interference or over-expression vectors were constructed to regulate the expression of NOD1 in M1 macrophages. M0 macrophages were pretreated with IL-37 recombinant protein and then incubated with LPS and IFN-γ for induction. The expression of NOD1, IL-37, M1 markers (IL-6 and iNOS) and M2 markers (IL-10 and Arg-1) was quantified by qPCR. Western blot was employed to assess the protein level of NOD1, NF-kB p65, and p-NF-kB p65. Co-immunoprecipitation was used to detect the interaction between NOD1 and IL-37. Results Up-regulation of NOD1 and down-regulation of IL-37 as were found in inflammatory breast tissues(P<0.05). Compared to M0 cells, M1 cells showed up-regulated NOD1 and M1 markers and the elevated phosphorylated NF-κB p65 but the down-regulated IL-37(P<0.05). In M1 macrophages, both NF-κB inhibitor and NOD1 knockdown led to the down-regulation of NOD1 and M1 markers and caused a decrease in the phosphorylated NF-κB p65(P<0.05). IL-37 recombinant protein decreased phosphorylation of NOD1, M1 marker and NF-κB p65, which was reversed by over-expression of NOD1. IL-37 may interact with NOD1(P<0.05). Conclusions IL-37 may inhibit M1 polarization in macrophages by down-regulating NOD1/NF-κB pathway thereby preventing plasma cell mastitis progression.

Key words: plasma cell mastitis, macrophage, M1 polarization, interleukin-37, nucleotide oligomerization structural domain receptor protein 1

中图分类号: